4.7 Article

Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP

Journal

SENSORS AND ACTUATORS B-CHEMICAL
Volume 345, Issue -, Pages -

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2021.130411

Keywords

Coronavirus disease; Loop-mediated isothermal amplification; CRISPR; Cas; Gold nanoparticle; High-throughput on-site detection

Funding

  1. Innovation Capacity Building Project of Jilin Provincial Development and Reform Commission [2021C035-6]
  2. Fundamental Research Funds for the Central Universities [20lgzd28]
  3. Guangdong Province Science and Technology Innovation Special Fund (International Scientific Cooperation) [2018A050506035]

Ask authors/readers for more resources

The development of a gold nanoparticle-based visual assay combined with CRISPR/Cas12a-assisted RT-LAMP for rapid and sensitive detection of SARS-CoV-2 shows promise in improving COVID-19 screening efforts. This method is easy to operate and has high-throughput testing capability, with potential applications in screening suspected individuals in various settings.
The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed, few tests could be performed for high-throughput analysis. We here developed a gold nanoparticle-based visual assay that combines with CRISPR/Cas12a-assisted RT-LAMP, which is called Cas12a-assisted RT-LAMP/AuNP (CLAP) assay for rapid and sensitive detection of SARS-CoV-2. In optimal condition, we could detect down to 4 copies/mu L of SARS-CoV-2 RNA in 40 min. by naked eye. The sequence-specific recognition character of CRISPR/Cas12a enables CLAP a superior specificity. More importantly, the CLAP is easy for operation that can be extended to high-throughput test by using a common microplate reader. The CLAP assay holds a great potential to be applied in airports, railway stations, or lowresource settings for screening of suspected people. To the best of our knowledge, this is the first AuNP-based colorimetric assay coupled with Cas12 and RT-LAMP for on-site diagnosis of COVID-19. We expect CLAP assay will improve the current COVID-19 screening efforts, and make contribution for control and mitigation of the pandemic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available